Xinnate

Lund, Sweden · Founded 2019 · Privately Held (backing)

Developer of a biopharmaceutical platform intended to develop proprietary peptides for the prevention and treatment of wounds and topical applications. Xinnate is based in Lund, Sweden and was founded in 2019. Its last reported valuation was $38.8 million in Dec 2022. It has raised $16.1 million.

Last reported valuation

$38.8M

Oct 2026

Priced at

—

Total raised

$16.1M

Last round

—

How much has Xinnate raised?

$16.1Macross 0 recorded rounds

Free account

More of Xinnate with a free account

·Watch Xinnate: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Xinnate investors

4 investors are on record for Xinnate, including United States Department of War, Jinderman & Partners, SmiLe Incubator and Swedish Research Council.

For fundraisers

Raising for a company like Xinnate?

4 investors have backed Xinnate.

See all 4 investors →

Frequently asked about Xinnate

How much has Xinnate raised?: Xinnate has raised $16.1M in total across 0 recorded funding rounds.